Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTTOM trial: botulinum toxin A versus topical diltiazem for chronic anal fissure
NL-OMON29443Recruiting
- Sponsor
- B.A. Twigt, E.A te Velde, L. Stoker, E. Kuck, A. Pronk
- Start
- Jun 2005
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in chronic anal fissure (CAF) comparing Botulinum toxin A injection + placebo ointment with Placebo injection + topical diltiazem ointment (2 arms). Primary endpoint: Healing of fissure. Started Jun 2005; status: recruiting.
02
Drugs
botulinum toxin type Adiltiazem
03
Conditions
chronic anal fissure (CAF)
Beyond the preview
Go deeper on NL-OMON29443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29443.